This review provides a comprehensive summary of recent advances in the α-syn/TLRs/NF-κB/NLRP3 inflammasome axis of microglia as a useful advent for PD management by inhibiting microglial activation. The gene discussed is NFKB1; the disease is Parkinson disease.